IP Verse

Aquestive Therapeutics, Inc. formerly Monosol RX, LLC v. Neurelis, Inc. - IPR2019-00451

Explore the PTAB proceeding IPR2019-00451 filed by Aquestive Therapeutics, Inc. formerly Monosol RX, LLC against Neurelis, Inc. on Jan 29, 2019. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Case Details

Proceeding Number
IPR2019-00451
Filing Date
Jan 29, 2019
Petitioner
Aquestive Therapeutics, Inc. formerly Monosol RX, LLC
Respondent
Neurelis, Inc.
Status
Final Written Decision
Respondent Application Number
14527613
Respondent Tech Center
1600
Respondent Patent Number
9763876
Institution Decision Date
Aug 13, 2019
Termination Date
Aug 6, 2020

Decision Documents New

Decision pending - set alert to receive updates

Counsels Involved New

Details of counsels involved in proceeding number IPR2019-00451.

TypeName
Petitioner CounselDaniel Scola
Respondent CounselJeffrey Guise

Proceeding Documents

The table below shows documents filed in the case, listing each document name, filing date, document type, and filing party. Tracking these filings indicates the activity of the parties involved in the case, and the types of documents filed can provide insights into the legal strategies being employed.